European Journal of Pharmaceutics and Biopharmaceutics

Papers
(The H4-Index of European Journal of Pharmaceutics and Biopharmaceutics is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board144
Authors’ reply to comments on “Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt”141
Editorial Board126
Editorial Board123
Long-term exposure in high viscous microenvironment facilitates acquired drug resistance of colon cancer cells to doxorubicin108
Unravelling the polysorbate 20 composition: A fusion of UPLC-MS analysis and stochastic modelling97
Corrigendum to “Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy” [Eur. J. Pharm. Biopharm. 211 (2025) 114714]90
Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration79
Viscosity increase/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes74
Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles65
COSMO models for the pharmaceutical development of parenteral drug formulations63
In-situ sequential crystallization of fenofibrate and tristearin – Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallizatio52
Liquid crystal phase formation and non-Newtonian behavior of oligonucleotide formulations52
Porous hydroxyapatite carrier enables localized and sustained delivery of honokiol for glioma treatment50
Mechanisms of polysorbate 80 oxidation: Acetate and Fe(III) mediated near UV and visible light degradation enhanced by free fatty acids48
Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody47
Topical liquid formulation of bacteriophages for metered-dose spray delivery47
A comparative study of gellan gum and xanthan gum versus commercial vehicles as pharmaceutical thickening agents in oral suspensions47
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategy46
Homogeneity and mechanical properties of orodispersible films loaded with pellets44
Strain- and species-specific immune responses to human adipose stem cell-derived extracellular vesicles: A comparative pharmacological evaluation in mice and human PBMCs44
Harnessing dicarboxylate-based salts for enhancing the performance of amorphous solid dispersions: The case of olanzapine43
Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response42
Rationalisation of the purification process for a phage active pharmaceutical ingredient41
Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: A biochemical, behavioral, and histological study41
Double-layer dissolving microneedles for delivery of mesenchymal stem cell Secretome: Formulation, characterisation and skin irritation study40
Question-based review for pharmaceutical development: An enhanced quality approach40
Less is more: Self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells39
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery39
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans38
Effect of the combination of ion-pairs strategies and permeation enhancers on iguratimod transdermal patch against rheumatoid arthritis37
Nose-to-Brain delivery of genistein-loaded peppermint lipid nanocapsules for neuroprotection against Alzheimer’s Disease: Formulation, Characterization, pharmacokinetic and Pharmacodynamic studies37
Release profiles prediction of diclofenac sodium patches using Raman mapping technique37
Editorial Board37
Formulation strategies to provide oxygen-release to contrast local hypoxia for transplanted islets36
Metal complex lipid-based nanoparticles deliver metabolism-regulating lomitapide to overcome CTC immune evasion via activating STING pathway35
0.088277101516724